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Abstract
Background: The objective of these analyses is to document the relationship between biomarker-based indicators
of health and socioeconomic status (SES) in a low-income African population where the cumulative eﬀects of
exposure to multiple stressors on physiological functions and health in general are expected to be highly detrimental
for the well-being of individuals.
Methods: Biomarkers were collected subsequent to the 2008 round of the Malawi Longitudinal Study of Families
and Health (MLSFH), a population-based study in rural Malawi, including blood lipids (total cholesterol, LDL, HDL, ratio
of total cholesterol to HDL), biomarkers of renal and liver organ function (albumin and creatinine) and wide-range
C-reactive protein (CRP) as a non-speciﬁc biomarker for inﬂammation. These biomarkers represent widely used
indicators of health that are individually or cumulatively recognized as risk factors for age-related diseases among
prime-aged and elderly individuals. Quantile regressions are used to estimate the age-gradient and the within-day
variation of each biomarker distribution. Diﬀerences in biomarker levels by socioeconomic status are investigated
using descriptive and multivariate statistics.
Results: Overall, the number of signiﬁcant associations between the biomarkers and socioeconomic measures is very
modest. None of the biomarkers signiﬁcantly varies with schooling. Except for CRP where being married is weakly
associated with lower risk of having an elevated CRP level, marriage is not associated with the biomarkers measured in
the MLSFH. Similarly, being Muslim is associated with a lower risk of having elevated CRP but otherwise religion does
not predict being in the high-risk quartiles of any of the MLSFH biomarkers. Wealth does not predict being in the high-
risk quartile of any of the MLSFH biomarkers, with the exception of a weak eﬀect on creatinine. Being overweight or
obese is associated with increased likelihood of being in the high-risk quartile for cholesterol, Chol/HDL ratio, and LDL.
Conclusions: The results provide only weak evidence for variation of the biomarkers by socioeconomic indicators in
a poor Malawian context. Our ﬁndings underscore the need for further research to understand the determinants of
health outcomes in a poor low-income context such as rural Malawi.
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Background
Biomarker-based health indicators of physiological func-
tioning represent a critical link for understanding the
relationship between socioeconomic status (SES) and
disease presentation because they can reveal common
biological pathways between health and its socioeconomic
and environmental determinants [1,2]. For instance, some
studies have argued that individuals of low socioeconomic
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status have a higher prevalence of sub-clinical markers
of disease risk [3], and longitudinal studies of cardiovas-
cular disease (CVD) reveal that the individual’s relative
rank on the biomarkers for CVD such as lipids or blood
pressure tends to remain stable throughout the life course
[4-6]. This suggests that even if currently measured
biomarkers do not reveal a present clinical case, they
may nevertheless represent a useful tool to identify indi-
viduals who are high risk for developing a disease [4].
Currently, however, the evidence about the relationship
between SES and biomarkers of physiological health is
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mixed and derived primarily from studies in developed
contexts. For instance, Rosero-Bixby et al. [7] found that
metabolic conditions such as diabetes and cholesterol are
not associated with SES, while hypertension and obesity
worsen with higher SES. In a comparative multi-country
study, Goldman et al. [8] observed generally negative and
signiﬁcant associations between education and diﬀerent
biomarkers in the United States (U.S.), but non-systematic
and only weak associations in Taiwan and Costa Rica.
Alley et al. [9] showed variation of C-reactive protein
(CRP) by SES only at very high levels above 10mg/l, but no
diﬀerence at moderate or high levels of CRP, suggesting a
non-linear relationship between inﬂammation and SES, at
least in the U.S. context. Among the few studies in African
contexts, Rossi et al. [10] found that serum concentra-
tion of high-sensitivity CRP was signiﬁcantly associated
with sex, several cardiovascular risk factors, and selected
renal function markers in a Seychelles population. Studies
have also suggested that the association between SES and
biomarkers of health is stronger in developed than in the
less-developed contexts, possibly due to the higher levels
of social stratiﬁcation in the industrialized world [8]. In
addition, diﬀerences in nutritional patterns, ethnic origin,
or exposure to environmental pathogens can potentially
alter hematological and immunologic indicators and thus
contribute to the variation of biomarkers between African
and Western populations [11].
The present study contributes to the emerging litera-
ture on biomarker-based health indicators in sub-Saharan
Africa (SSA) by analyzing SES diﬀerentials in several
biomarkers collected as part of the Malawi Longitudinal
Study of Families and Health (MLSFH) in the southern
region of Malawi (Balaka). The objective of this analysis
is to document the relationship between these biomarker-
based indicators of health and socioeconomic status (SES)
in a low-income African population where the cumulative
eﬀects of exposure to multiple stressors on physiological
functions and health in general are expected to be highly
detrimental for the well-being of individuals.
Methods
Study context
The MLSFH is a longitudinal study of the rural popu-
lation in Malawi that provides an exceptional record of
the social, economic, and health conditions in one of the
world’s poorest nations. TheMLSFH is based in three dis-
tricts in rural Malawi that have been the study sites since
1998: Rumphi in the north, Mchinji in the center, and
Balaka in the south. Respondents (N2008 ≈ 4, 000) are
evenly split among the three study locations and clustered
in 121 villages. The study population is broadly represen-
tative of the overall rural population inMalawi [12], and is
similar in many socioeconomic and health conditions to
other low-income countries in SSA [13]. MLSFH rounds
were collected in 1998, 2001, 2004, 2006, 2008, and 2010.
All three MLSFH sites are rural, and subsistence agricul-
ture is the predominant economic activity among study
participants. Balaka, which is the site for which biomark-
ers were collected in 2009, follows a matrilineal system of
kinship and lineage system, and it is primarily inhabited by
Lomwes and Yaos and has thus the highest proportion of
Muslims among MLSFH regions. The Balaka region also
exhibits a lower age of sexual debut and larger numbers
of lifetime sexual partners than the other MLSFH study
regions, and residents tend to be less educated and poorer
than those living in the north, leading to higher levels of
migration. HIV/AIDS prevalence in the southern region
is signiﬁcantly higher than in the northern and central
region [14].
MLSFH biomarkers and SES indicators
Our analyses focus on three groups of biomarkers:
blood lipids (total cholesterol, high-density lipoprotein
[HDL], low-density lipoprotein [LDL], and the ratio of
total cholesterol to HDL), biomarkers of renal and liver
organ function (albumin and creatinine), and wide-range
C-reactive protein (CRP) as commonly used and reli-
able indicator of non-speciﬁc inﬂammation. The three
groups represent a fairly broad set of biomarkers that
embody multiple physiological processes and have indi-
vidually as well as cumulatively been linked to important
age-related health outcomes, including cardiovascular
diseases, cognitive decline, physical performance, and
death [15-17]. The selected biomarkers also represent
commonly used biological indicators with demonstrated
analytical power in population-based studies from both
developed and less-developed countries [11,18-27]. For
example, lipids are widely considered a risk factor for
cardiovascular disease in the developed and develop-
ing countries [26-31], and the ratio of total cholesterol
to HDL is a predictor of ischemic heart disease risk in
asymptomatic individuals [23,32,33]. Low concentra-
tions of albumin have been positively related to coronary
artery disease and are also correlated with inﬂammation
and malnutrition, while high levels are positively corre-
lated with dehydration. In HIV-positive or malnourished
individuals—both conditions are frequently occurring
and co-existing in the Malawian rural population and SSA
in general—creatinine levels may be elevated. In addition,
renal diseases, and speciﬁcally chronic kidney disease,
are among the leading causes of morbidity and mortality
worldwide, and are understudied in SSA contexts [34-37].
SES indicators available in the MLSFH include: (i)
respondent’s level of formal education (measured as no
schooling, primary, and secondary schooling); and (ii)
wealth indicators such as having a house covered with
a metal roof and the wealth tertile based on an index
constructed from dwelling characteristics and ownership
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of household durable assets using principal component
analyses [38]. In addition, our analyses include other rele-
vant aspects of the respondent’s demographic and socioe-
conomic context such as the respondent’s marital status
(coded as married versus non-married) and religious aﬃl-
iation (Christian, Muslim, and others). We also include
body mass index (BMI) in the analysis since it is con-
sidered as a reliable indicator of current health problems
(e.g., malnutrition, presence of HIV infection, and others).
Data collection
The MLSFH collected blood-serum biomarker data along
with a short survey for about 980 randomly selected
respondents in the southern region of Balaka in January–
February 2009. The details of the MLSFH biomarker
collection are described in a companion paper [39],
and IRB approval was obtained from the University of
Pennsylvania and the Malawi National Health Sciences
Research Council (NHSRC). As stipulated in these IRB
protocols and the general regulations for conducting
human subjects research, informed consent was obtained
from all study participants prior to the participation in
this study. The consent form clearly stated that the data
are collected as part of a research project. The Balaka
region was chosen for the MLSFH biomarker collection
because of its relatively high HIV prevalence. All partic-
ipants for the MLSFH biomarker sample were selected
from MLSFH respondents who were successfully inter-
viewed during the 2008 MLSFH wave, and the 2009
MLSFH biomarker sample is linked to all prior and sub-
sequent MLSFH data collected for this study population.
The target sample for the MLSFH biomarker collection
was selected in two stages from the MLSFH respondent
database. First, all respondents who were found HIV
positive in a previous MLSFH round were included in the
sample. Second, a random sample of approximately 1,500
respondents (aged ≥ 18 years) was drawn from the 2,500
MLSFH respondents residing in Balaka. The biomarker
and survey data collection was conducted at respondents’
homes. Because of weather obstacles (rainy season), high
levels of work-related migration in this region, and other
temporary absences that resulted in failures to re-contact
MLSFH respondents, we were able to successfully contact
1,031 individuals in the target sample. These individuals
were oﬀered to participate in theMLSFH biomarker study.
Forty-nine respondents (4.7%) refused to participate, and
the MLSFH successfully collected biomarker specimens
for 982 respondents (95.2% of contacted individuals).
Sixty-two study participants had previously tested posi-
tive for HIV (7.3% among those with known HIV status).
The MLSFH biomarker data collection used LabAny-
where kits (LabAnywhere, Harlem, the Netherlands; for-
merly known as Demecal) that require only a few drops
of blood harvested from a lancet puncture of a sanitized
ﬁngertip. The reliability, sensitivity, and speciﬁcity of the
test kits have been demonstrated by LabAnywhere in the
Netherlands, and the applications of test-speciﬁc recov-
ery factors yielded a good correlation with results of
venous blood samples [40]. The LabAnywhere technol-
ogy used in our study oﬀers several advantages over
the other common means of collecting blood samples
in population-based studies such as dried blood spots
(DBS) or venipuncture [41], including the extraction of
blood plasma in ﬁeldwork contexts with minimal dis-
comfort for participants and the ability to conduct up
to 16 assays with each sample. To collect the specimen
for the LabAnywhere kits at respondents’ homes, the
MLSFH recruited a team of 25 individuals who had previ-
ously been trained by the Malawian Government in ﬁnger
prick blood collection as part of HIV voluntary counsel-
ing and testing. These biomarker collectors underwent an
additional one-week of training in the use of the LabAny-
where kits, and each collector then completed about two
to four home-based data biomarker and survey collec-
tions per day during ﬁeldwork. While in the ﬁeld during
the day, the collected specimen were stored in a cooler.
Upon returning from the ﬁeld each day, the biomarker
coordinator checked all samples to verify that they were
collected and labeled properly; all plasma samples were
stored in a -20°C freezer until they were shipped to the
LabAnywhere laboratory on a weekly schedule. Prior to
the shipment, all biomarker samples were cross-checked
with ﬁeld records. Shipment was via DHL from Malawi
to the LabAnywhere laboratory in the Netherlands. The
samples were packed in a special cooler with ice packs
provided by LabAnywhere, which were designed speciﬁ-
cally for transporting the frozen blood samples, including
minimum/maximum thermometers to monitor the cool-
ing conditions. LabAnywhere was able to analyze 910
(92.7%) of the 982 samples they received. None were dis-
carded because of inadequate temperature control. The
duration between the collection of each specimen and the
analysis by LabAnywhere was almost always less than two
weeks.
Analytical approach
Descriptive statistics are used to present the distribu-
tion of each biomarker by gender. Quantile regressions
of the 25th, 50th (median), and 75th percentile of each
biomarker distribution on age are used to estimate the
age-gradient of each biomarker distribution. Analogous
quantile regressions on the time (hour) of the data col-
lection were used to investigate intra-day variation in
all biomarker distribution. To investigate diﬀerences in
biomarker levels by socioeconomic characteristics, we fol-
low the analytical approach of Dowd and Goldman [42]
and apply logistic regressions using as dependent vari-
able whether the biomarker value falls into the highest
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quartile of the observed distribution. This approach is
advantageous compared to a linear speciﬁcation if a risk
for disease is associated with very low or very high values
of the biomarkers; this approach is also relatively robust
with respect to outliers in the biomarker distributions.
Depending on the biomarker of interest, the highest-risk
quartile can correspond to either low or high values. For
instance, for total cholesterol, HDL, creatinine, CRP, and
the ratio of total cholesterol to HDL the highest quar-
tile corresponds to the 75th percentile of the distribution,
while for albumin it corresponds to the 25th percentile.
The logistic regression analyses are pooled for men and
women to increase the statistical power of our analysis. All
models control for sex of the respondents, age group (sep-
arate for males/females), and currently pregnant (females
only). The results obtained from these logistic regres-
sion analyses with respect to biomarker diﬀerences by
socioeconomic characteristics are identical with those
obtained from multivariate linear regression using the log
biomarker values as outcome (Additional ﬁle 1).
Results and discussion
Descriptive statistics of the study population in Balaka are
shown in Table 1. The average age of females included
in the analysis is about 42 years, while men are on
average 1 year older. The majority of the respondents
(80% of women and 90% of men) are currently married.
The Balaka region is predominantly Muslim and this is
reﬂected in our sample: about 70% of the respondents
are Muslim, while the remaining 30% are either Christian,
belong to other religions, or are without religious aﬃlia-
tion. Women are on average less educated than men. For
instance, 58% of women do not have any formal educa-
tion, but only 32% of men fall into this category. Only
3% of women, but twice as many men, have secondary
level of schooling. The majority of the respondents (80%
of women and 84% of men) have normal body mass index
as measured in 2008, the year prior the biomarker data
collection. The data show that overweight and obesity are
not common at all in rural Malawi, and only 7% of all
respondents are overweight and 1% are obese, with both
more prevalent among women than men. About 60% of
the respondents rate their health status as being either
very good or excellent, and only 16% of women and 10%
of men rate it as being fair or poor. The majority of the
MLSFH respondents reports better or much better health
relative to others from the same sex and age group in the
village.
Summary statistics of the distribution of the biomark-
ers of interest are shown in Table 2. The distribution of
the biomarkers deviates substantially from the distribu-
tions observed in the U.S. and other Western populations,
and the observed values in our sample fall almost without
exception below the clinically established levels used in




# of observations 571 335 906
Age (in 2008) 42.17 43.54 42.68
(17.75) (16.87) (17.43)
Married (in 2008) 0.76 0.89 0.81
Muslim 0.69 0.71 0.70
2008 level of education
No school 0.57 0.32 0.48
Primary level 0.40 0.62 0.48
Secondary level 0.03 0.06 0.04
Body mass index (BMI) (2008)
Underweight (BMI < 18.5) 0.14 0.12 0.14
Normal (18.5 ≤ BMI < 25) 0.75 0.83 0.78
Overweight (25 ≤ BMI < 30) 0.09 0.04 0.07
Obese (BMI ≥ 30) 0.02 0.01 0.01
Subjective health
Fair/Poor 0.16 0.10 0.14
Good 0.31 0.19 0.26
Very good 0.28 0.30 0.29
Excellent 0.26 0.41 0.31
Relative health to others in village
Worse 0.07 0.05 0.06
Same 0.31 0.28 0.30
Better 0.50 0.41 0.47
Much better 0.12 0.26 0.17
Number of recent econ shocks 2.00 1.88 1.95
(0.91) (0.95) (0.92)
industrialized countries to identify individuals at risk for
adverse health outcomes [39]. This pattern is not entirely
unexpected since, for instance, changes in lipoproteins
are noted to occur during an acute-phase reaction to
inﬂammation that is common in Malawi [43]. Similarly,
inﬂammation and acute phase proteins may alter/reverse
cholesterol transport by HDL [44]. As a consequence
of the distribution of the biomarker levels in Table 2, a
very low number of respondents can be characterized as
high risk based on established clinical cutpoints for these
biomarkers. In a prior study describing the methodology
of the data collection, we tested the validity of our mea-
surement approach and showed that this distribution of
the biomarkers is not an artifact of measurement issues
or problems [39], but it is similar to patterns observed
in other low-income populations such as the Tsimane
in Bolivia [45-47] or the Yakuts in Siberia who are, for
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Table 2 Summary statistics for the biomarker-based health indicators
N Mean std. Percentiles Age-Gradient
25th 50th 75th of median
Total cholesterol (Chol) (mg/dL)
Female 571 115.1 29.8 92.7 112.0 135.1 0.43∗∗
Male 336 103.5 37.9 83.0 100.4 119.7 0.64∗∗
Total 907 110.8 33.5 88.8 108.1 131.3 0.36∗∗
High-density cholesterol (HDL) (mg/dL)
Female 571 33.4 11.6 27.0 30.9 42.5 0.00
Male 336 28.4 9.89 23.2 27.0 34.7 0.18∗∗
Total 907 31.6 11.2 23.2 30.9 38.6 -0.06
Chol/HDL Ratio
Female 571 3.78 1.57 2.87 3.45 4.22 0.014∗∗
Male 336 3.97 1.73 3.00 3.63 4.40 0.002
Total 907 3.85 1.63 2.90 3.50 4.29 0.005∗
Low-density cholesterol (LDL) (mg/dL)
Female 571 61.9 23.1 46.3 57.9 77.2 0.30∗∗
Male 336 53.9 28.5 38.6 50.2 65.6 0.45∗∗
Total 907 58.9 25.5 42.5 57.9 73.4 0.20∗
Creatinine (mg/dL)
Female 571 0.67 0.17 0.54 0.66 0.76 0.002∗∗
Male 336 0.84 0.19 0.71 0.81 0.94 0.000
Total 907 0.73 0.20 0.60 0.71 0.84 0.002∗
Albumin (g/dL)
Female 571 3.66 0.49 3.39 3.66 3.94 -0.003∗∗
Male 336 3.55 0.51 3.25 3.52 3.84 -0.008∗∗
Total 907 3.62 0.50 3.33 3.62 3.91 -0.006+
C-reactive protein (CRP)
Female 561 3.82 11.0 0.20 0.50 2.30 0.006∗
Male 332 4.99 12.2 0.20 0.80 3.00 0.013∗
Total 893 4.26 11.5 0.20 0.60 2.60 0.002∗∗
Age gradient of median is the coef of a quantile regression of the 50th percentile on age. p-values: + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01.
instance, also characterized by very low CRP levels com-
pared to the U.S. population samples [48,49].
The analysis of the age-gradient reveals that the dis-
tribution of cholesterol is shifted upward for older indi-
viduals (Table 2 and Figure 1); the same is the case for
HDL (men only), Chol/HDL Ratio (women only), LDL,
and creatinine (women only). Albumin declines with age.
Similar age-gradients were also found at the 25th and
75th percentile of the biomarker distributions (results not
reported in detail). Even where the age-gradient is statis-
tically signiﬁcant, age explains only a very small fraction
of the variation in the biomarkers: Pseudo-R2 of all age-
gradient regressions are below .05 in all cases except for
some regressions for cholesterol and one for LDL where
the Pseudo-R2 reaches values between .07–.09. Quantile
regressions of the 25th, 50th, and 75th percentile on dum-
mies for the hour of biomarker collection during each day
and gender (not reported in detail) show that, with the
exception of the 25th percentile for albumin, there is no
systematic time variation of the biomarker distributions
within each ﬁeldwork day: the null hypotheses that 25th,
50th, and 75th percentile does not vary by hour of day is
never rejected at the 5 percent level, with exception of the
25th percentile for albumin where a weak inverse U-shape
is detected. HDL and albumin levels are signiﬁcantly lower
amongHIV+ as compared toHIV– respondents (p < .01),
while CRP levels and the Chol/HDL ratio are elevated
amongHIV+ as compared toHIV– respondents (p < .01).
Table 3 shows odds ratios for the probability that
a respondent is in the highest-risk quartiles of the
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Figure 1 Relative change in median value of biomarker for a
1-year increase in age (separate analyses for females andmales).
biomarker distribution by schooling, marital status, reli-
gion, wealth, and BMI. Overall, the number of signiﬁcant
associations between the biomarkers and socioeconomic
measures is very modest. None of the biomarkers sig-
niﬁcantly varies with schooling, despite the fact that
schooling has been shown to be an important health and
socioeconomic indicator in this and related contexts [50].
Despite the widely documented association between mar-
riage and better health [51], marriage is not associated
with the biomarkers measured in the MLSFH; the only
exception is CRP where being married is weakly associ-
ated with lower risk of having an elevated CRP level (at
10% statistical signiﬁcance). The same lack of a strong
association is found for religion, where being Muslim is
associated with a lower risk of having elevated CRP but
otherwise does not predict being in the high-risk quartiles
of any of the MLSFH biomarkers. Despite widely docu-
mented associations between wealth and health [38,52],
wealth does not predict being in the high-risk quartile
of any of the MLSFH biomarkers (only one association
between creatinine and the highest wealth tertile is sig-
niﬁcant at the 10% level). The lack of strong associations
between the biomarker levels and socioeconomic indi-
cators such as schooling, marital status, religion, and
wealth is also found in identical fashion in multivari-
ate regression analyses using the log biomarker levels as
continuous outcomes (Additional ﬁle 1: Table S1). Consis-
tent with research that increasingly emphasizes elevated
levels of BMI as a health concern also in developing coun-
tries [53,54], being overweight or obese—which is the
case for 8.7% of the MLSFH respondents in the anal-
yses sample—is associated with increased likelihood of
being in the high-risk quartile for cholesterol, Chol/HDL
ratio, LDL (Table 3). For all biomarkers, the point esti-
mates suggest that being underweight is associated with
a reduced likelihood, and being overweight is associated
with an increased likelihood of being in the high-risk
quartile of the biomarker distribution, but except where
noted above, the estimates are not signiﬁcant at the
5% level.
The lack of signiﬁcant associations between theMLSFH
biomarkers and SES is not due to a lack of statistical
power. Our analyses document signiﬁcant age patterns
for several biomarkers, signiﬁcant associations between
BMI and several biomarkers (cholesterol, Chol/HDL ratio,
LDL levels), signiﬁcant diﬀerences in the expected direc-
tion in four out of the seven biomarkers between HIV+
and HIV– respondents, and associations between CRP
and marital status and religion that are in the expected
directions. These statistically signiﬁcant ﬁndings suggest
that our analyses are in principle adequately powered to
detect diﬀerences in the MLSFH biomarkers by SES and
other indicators (which is consistent with the power cal-
culations used in designing this study). The failure to
document important socioeconomic variation in many of
our analyses therefore seems not due to an inadequate
sample size, but rather due to a lack of strong associations
between the MLSFH biomarkers and our socioeconomic
indicators.
Conclusions
Biomarker-based health indicators of physiological func-
tioning represent a critical link for understanding the rela-
tionship between socioeconomic status (SES) and disease
presentation. And yet, current evidence about SES diﬀer-
entials in biomarker-based healthmeasures among prime-
aged and elderly individuals remains inconclusive. Our
analyses focus on commonly used biomarkers of cardio-
vascular risk, non-speciﬁc inﬂammation, and renal/liver
function that are individually or cumulatively recognized
as risk factors for age-related diseases among prime-aged
and elderly individuals: total cholesterol, LDL, HDL, ratio
of total cholesterol to HDL, albumin, creatinine, and wide-
range CRP. And while a large body of research has docu-
mented diﬀerences in these biomarkers by socioeconomic
indicators in other contexts [7-11,42,55-60], the variation
of these biomarkers in the Malawian—or similar poor
high-morbidity contexts in SSA—is still not well estab-
lished. However, analyses of the SES variation in these
biomarker-based health indicators are an important addi-
tion to the existing literature on socioeconomic health
diﬀerentials in adult populations because most existing
studies in SSA are often based on self-reported measures
of health and disability, and only for HIV and some other
infectious diseases, on biomarkers. At this point, little
is known from biomarker-based studies about the levels,
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Table 3 Odds ratios for the probability of being in the highest risk quartiles of the biomarker distributions: BMI,
subjective health and other self-reported health measures (logistic regressionmodels, both sexes combined)
Cholesterol HDL Chol/HDL ratio LDL Creatinine CRP Albumin
Model 1: Schooling
No Schooling ref. ref. ref. ref. ref. ref. ref.
Primary Schooling 1.04 1.08 1.33 1.13 1.14 1.27 0.91
[0.70,1.55] [0.75,1.55] [0.91,1.95] [0.76,1.66] [0.75,1.72] [0.87,1.85] [0.63,1.31]
Secondary Schooling 0.79 0.62 1.39 0.54 1.98 1.22 0.62
[0.25,2.56] [0.25,1.50] [0.56,3.45] [0.15,1.94] [0.79,4.97] [0.50,2.97] [0.22,1.76]
Model 2: Marital status
Married (in 2008) 1.11 0.80 0.94 1.08 0.99 0.65+ 1.02
[0.69,1.79] [0.52,1.22] [0.61,1.46] [0.68,1.72] [0.60,1.63] [0.42,1.01] [0.64,1.61]
Model 3: Religion (major groups)
Christian/Other/None ref. ref. ref. ref. ref. ref. ref.
Muslim 1.18 0.89 0.95 1.07 0.68+ 0.68∗ 0.85
[0.80,1.73] [0.63,1.24] [0.67,1.36] [0.74,1.55] [0.47,1.00] [0.48,0.95] [0.60,1.20]
Model 4: Wealth (based on asset-based wealth tertiles)
1st (poorest) 1.05 1.17 0.79 1.09 1.38 0.77 0.97
[0.68,1.62] [0.79,1.72] [0.52,1.19] [0.71,1.67] [0.88,2.15] [0.52,1.16] [0.66,1.44]
2nd (middle) ref. ref. ref. ref. ref. ref. ref.
3th (wealthiest) 1.08 1.25 1.15 1.30 1.49+ 1.02 0.75
[0.70,1.67] [0.85,1.85] [0.77,1.71] [0.86,1.99] [0.94,2.34] [0.68,1.52] [0.50,1.13]
Model 5: Bodymass index (BMI) (reference category: normal)
Underweight 0.81 0.74 0.63 0.77 0.55+ 0.69 1.42
[0.45,1.46] [0.42,1.31] [0.34,1.16] [0.43,1.39] [0.28,1.06] [0.39,1.24] [0.85,2.36]
Normal ref. ref. ref. ref. ref. ref. ref.
Overwght/obese 2.11∗ 1.14 2.65∗∗ 2.65∗∗ 1.39 1.35 0.71
[1.14,3.90] [0.59,2.18] [1.46,4.81] [1.46,4.81] [0.68,2.86] [0.69,2.62] [0.34,1.47]
BMI missing 1.00 1.54∗ 1.52∗ 1.20 0.79 1.13 1.01
[0.66,1.51] [1.09,2.16] [1.06,2.18] [0.80,1.79] [0.53,1.17] [0.78,1.62] [0.70,1.46]
p-values: + p < 0.10, ∗ p < 0.05, ∗∗ p < 0.01. 95% Conﬁdence intervals in parentheses. Models control for gender, age group (separate for males/females), and
currently pregnant (females only).
variations, and determinants of cardiovascular risk, non-
speciﬁc inﬂammation, and renal/liver function in poor
high-morbidity SSA populations. And as the epidemio-
logical transition in SSA progresses and chronic diseases
constitute a growing proportion of the SSA disease burden
[61], these questions will become increasingly important.
And quite possibly, the story emerging from biomarker-
based indicators of physiological functions and health
could point to a more complex interpretation of the deter-
minants of adults health in contexts such as Malawi than
conclusions that are often based on self-reported health
measures and/or are frequently focused on infectious
diseases.
Our analyses are also important from a methodological
standpoint. For instance, to which extent are biomarkers
such as those collected as part of the MLSFH suitable
for identifying health diﬀerentials in poor high-morbidity
SSA contexts such as Malawi? And to what extent do
they provide comparable data on physiological function-
ing? And do these biomarkers exhibit the same socioeco-
nomic gradients in Malawi that have been documented
for these biomarkers in other contexts, or do they exhibit
the same gradients as other (mostly self-reported) health
indicators?
The key ﬁndings of our study point to an important
“puzzle”: Despite strong hypothesis for the existence of
SES diﬀerentials in health (and the MLSFH biomarkers
in particular), our results provide only weak evidence
for variation in the MLSFH biomarkers for cardiovas-
cular risk, non-speciﬁc inﬂammation, and renal or liver
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functioning by socioeconomic status. Moreover, only for
a small proportions of respondents do any of the MLSFH
biomarkers fall outside the limits of the normal clini-
cal ranges as deﬁned by Western standards [39]. Com-
bined these ﬁndings are important because it has been
suggested that biomarker-based indicators of health can
provide a useful tool to model and understand the path-
ways of how socioeconomic characteristics relate and
inﬂuence physiological functioning [62-64]. However, the
lack of important SES variation and the shifted dis-
tribution of the MLSFH biomarker (Table 2) as com-
pared to those observed in more developed contexts
raises the possibility that speciﬁc contexts of individu-
als in poor high-morbidity SSA environments importantly
aﬀect the distribution of these biomarkers and their asso-
ciation with SES and other behavioral/contextual covari-
ates. Our ﬁndings thus underscore the need for further
research to understand the determinants of the levels
and variations in biomarker-based health indicators that
measure cardiovascular risk, inﬂammation and renal or
liver function. In poor high-morbidity SSA contexts, the
variation in these indicators is currently understudied.
However, a better understanding of the determinants
and variation of these biomarker-based health indica-
tors can importantly contribute to an improved under-
standing of adult health that is construed more broadly
than is currently the case in many studies that focus on
either self-reported health measures or infectious dis-
eases. Only if the usefulness and validity of such biomark-
ers can be established does it make sense to further
expand biomarker-based health measures in population-
based surveys in poor high-morbidity SSA contexts to
obtain information about otherwise unobserved dimen-
sions of health. And while the technological challenges
for expanding biomarker-based health measures as part
of population-based studies in SSA are increasingly sur-
mountable, our ﬁndings highlight the potential ongoing
challenges in interpreting and comparing these measures
within SSA populations and across diverse cross-country
contexts.
The strengths of this study include the population-based
design; the availability of multiple biomarkers providing
indicators of cardiovascular risk, non-speciﬁc inﬂamma-
tion, and renal/liver function; a home-based data col-
lection; a high participation rate; and the integration
in a longitudinal cohort study with extensive socioe-
conomic, demographic, and health information. Among
the potential limitations of the present analyses is the
fact that these results pertain to a small limited popu-
lation from a discrete region in rural Malawi. Speciﬁ-
cally, the analyses are based on data from the southern
region of Balaka, an area that is predominantly Muslim.
The sample size comprises about 900 individuals and
is at most representative for this part of the country,
but not of the entire Malawian population. It is pos-
sible that while the link between socioeconomic status
and blood lipids, creatinine, albumin and wide-range CRP
in this setting is similar to the observations in other
developed countries, the pathways are diﬀerent in this
cultural setting and are not captured by these analyses.
Moreover, while we measure biomarkers that are seen as
a standard for health assessment in primarily Western
elderly populations, they may not be the best measure
for assessing health status in the SSA context. It is also
possible that the associations between the biomarkers
and the socioeconomic indicators may be confounded
by other risk factors such as nutritional deﬁcits and
episodic malnutrition, high prevalence of smoking, and
presence of co-infections such as HIV, tuberculosis, or
endemic parasites. In the present study, we are how-
ever not able to control for these potentially confounding
factors.
Additional ﬁle
Additional ﬁle 1: Multivariate regression of log biomarker levels on
selected socioeconomic indicators (both sexes combined).
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